Indiva Ltd
XTSX:NDVA
Indiva Ltd
XTSX:NDVA
Price:
0.03
CAD
Market Closed
Market Cap:
CA$5.9m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Indiva Ltd
XTSX:NDVA
|
CA |
|
Caleres Inc
NYSE:CAL
|
US |
|
Evolva Holding SA
SIX:EVE
|
CH |
|
Asia-Pacific Strategic Investments Ltd
SGX:5RA
|
SG |
|
Pro-Pac Packaging Ltd
ASX:PPG
|
AU |
|
Serabi Gold PLC
LSE:SRB
|
UK |
|
P
|
Platinum Analytics Cayman Ltd
NASDAQ:PLTS
|
SG |
|
Sixth Street Specialty Lending Inc
NYSE:TSLX
|
US |
|
Adhi Karya (Persero) Tbk PT
IDX:ADHI
|
ID |
Relative Value
There is not enough data to reliably calculate the relative value of NDVA.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NDVA
Relative Value
Base Case
Not Available
Multiples Across Competitors
NDVA Competitors Multiples
Indiva Ltd Competitors
Indiva Ltd Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| CA |
|
Indiva Ltd
XTSX:NDVA
|
5.9m CAD | 0.2 | -1.3 | -14 | -13.3 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
853.2B USD | 13.1 | 41.3 | 27.9 | 29.8 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
566.5B USD | 6 | 21.1 | 14.7 | 18.1 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
243.3B CHF | 4 | 18.9 | 11.2 | 12.6 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
213.1B GBP | 4.9 | 28.1 | 15.6 | 22 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288B USD | 4.4 | 15.8 | 9.8 | 11.9 | |
| CH |
|
Novartis AG
SIX:NOVN
|
222.8B CHF | 5.2 | 20.8 | 12.9 | 16.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.4 | 10.3 | 7.7 | 9 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.3B USD | 2.4 | 19.7 | 7.6 | 10.1 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
115.5B USD | 2.4 | 16.4 | 7 | 8.6 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
